Precigen Inc (PGEN)
1.42
+0.02
(+1.43%)
USD |
NASDAQ |
May 03, 16:00
1.425
0.00 (0.00%)
After-Hours: 20:00
Precigen Price: 1.42 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 1.45 | 1.49 | 1.39 | 1.42 | 599718.0 |
| May 02, 2024 | 1.43 | 1.44 | 1.33 | 1.40 | 753721.0 |
| May 01, 2024 | 1.34 | 1.455 | 1.31 | 1.40 | 683632.0 |
| Apr 30, 2024 | 1.39 | 1.41 | 1.31 | 1.32 | 496540.0 |
| Apr 29, 2024 | 1.41 | 1.459 | 1.40 | 1.40 | 381256.0 |
| Apr 26, 2024 | 1.40 | 1.44 | 1.39 | 1.41 | 413594.0 |
| Apr 25, 2024 | 1.40 | 1.41 | 1.37 | 1.40 | 611778.0 |
| Apr 24, 2024 | 1.40 | 1.43 | 1.39 | 1.42 | 568981.0 |
| Apr 23, 2024 | 1.40 | 1.45 | 1.39 | 1.40 | 507021.0 |
| Apr 22, 2024 | 1.32 | 1.39 | 1.32 | 1.38 | 890547.0 |
| Apr 19, 2024 | 1.30 | 1.34 | 1.28 | 1.33 | 1.013M |
| Apr 18, 2024 | 1.30 | 1.355 | 1.28 | 1.32 | 1.120M |
| Apr 17, 2024 | 1.39 | 1.405 | 1.30 | 1.31 | 811216.0 |
| Apr 16, 2024 | 1.41 | 1.42 | 1.33 | 1.36 | 847870.0 |
| Apr 15, 2024 | 1.40 | 1.42 | 1.37 | 1.40 | 1.223M |
| Apr 12, 2024 | 1.43 | 1.44 | 1.375 | 1.42 | 932148.0 |
| Apr 11, 2024 | 1.44 | 1.478 | 1.42 | 1.45 | 695083.0 |
| Apr 10, 2024 | 1.35 | 1.41 | 1.33 | 1.41 | 1.254M |
| Apr 09, 2024 | 1.41 | 1.46 | 1.40 | 1.41 | 313606.0 |
| Apr 08, 2024 | 1.40 | 1.46 | 1.40 | 1.41 | 649342.0 |
| Apr 05, 2024 | 1.39 | 1.43 | 1.35 | 1.40 | 515347.0 |
| Apr 04, 2024 | 1.41 | 1.415 | 1.36 | 1.36 | 618809.0 |
| Apr 03, 2024 | 1.38 | 1.41 | 1.35 | 1.40 | 635191.0 |
| Apr 02, 2024 | 1.43 | 1.43 | 1.36 | 1.39 | 823256.0 |
| Apr 01, 2024 | 1.47 | 1.485 | 1.42 | 1.43 | 520592.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8785
Minimum
Mar 27 2023
10.95
Maximum
Jan 04 2021
3.776
Average
3.23
Median
May 11 2020
Price Benchmarks
| Cyclacel Pharmaceuticals Inc | 2.00 |
| HealthEquity Inc | 78.55 |
| Corvus Pharmaceuticals Inc | 1.92 |
| Oragenics Inc | 1.07 |
| MAIA Biotechnology Inc | 3.28 |
Price Related Metrics
| PS Ratio | 55.61 |
| Price to Book Value | 2.983 |
| Earnings Yield | -27.46% |
| Market Cap | 353.47M |